Trial intelligence / Profile preview

18F-NaF vs 18F-Fluorocholine PET/CT in Prostate Cancer

NCT04340765Completed

Sponsor
Buddhist Tzu Chi General Hospital
Start
Feb 2018
Primary completion
Dec 2019
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Buddhist Tzu Chi General Hospital. Primary endpoints: Sensitivity of 18F-fluorocholine PET/CT and NaF PET/CT at 6 weeks and Specificity of 18F-fluorocholine PET/CT and NaF PET/CT at 6 weeks. Started Feb 2018; status: completed.

Beyond the preview

Go deeper on NCT04340765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04340765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call